Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Janus Living Inc. Class A-1 Common Stock (JAN) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Janus Living Inc. Class A-1 Common StockTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Janus Living Inc. Class A-1 Common Stock vs Marsh & McLennan Companies, Inc. — how do they compare? Janus Living Inc. Class A-1 Common Stock trades at $28.51 (market cap $6.79B), while Marsh & McLennan Companies, Inc. trades at $183.87 (market cap $85.13B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 12.5× Janus Living Inc. Class A-1 Common Stock's market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.22%). Which is the better fit depends on your goals — on Pluang, investors hold Janus Living Inc. Class A-1 Common Stock for 0 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.

JANMRSH
Market Cap
$6.79B$85.13B
Volume
1,802,8752,472,018
Sector
Real EstateFinancials
52-Week High
$31.76$203.85
52-Week Low
$22.88$157.32
Typical Hold Time
0 Days109 Days
Enterprise Value
$6.88B$105.82B
Dividend Yield
1.97%2.22%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Janus Living Inc. Class A-1 Common Stock

JAN trades at $28.85, up 0.42% today, with a neutral technical signal. The company, a senior housing REIT, reported a net loss of $61.10M in 2025, though revenue grew to $771.17M. Analyst sentiment is strongly positive with a 100% buy rating and a $32.91 consensus price target, representing a 14% upside. Recent developments include closing a $1.25 billion credit facility and declaring quarterly dividends.

The outlook is cautiously optimistic, driven by strong analyst support and strategic growth initiatives. Key opportunities include accretive acquisitions funded by recent capital raises. Risks include persistent negative profit margins, execution challenges in integrating new assets, and sensitivity to interest rate changes affecting REIT valuations.

Marsh & McLennan Companies, Inc.

Marsh (MRSH) trades at $177.01, up 0.27% on the day, with a bullish technical signal and strong fundamentals. The company reported revenue of $26.98 billion in 2025, with net income of $4.16 billion and a net margin of 15.41%. Recent earnings have consistently beaten estimates, and the company completed the acquisition of Accel Holdings in October 2026, signaling growth initiatives. Valuation ratios include a P/E of 21.61 and P/S of 3.09, while analyst consensus price target is $202.71.

The outlook for MRSH is positive, supported by earnings beats and strategic acquisitions, but risks include competitive pressures and potential margin compression. Analyst sentiment is mixed with a 'Hold' consensus, suggesting cautious optimism. The stock offers upside to the price target but faces execution risks in integrating acquisitions and maintaining profitability amid economic uncertainties.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JAN
100% Buy0% Sell
Avg holding period · 0 Days
MRSH
0% Buy100% Sell
Avg holding period · 109 Days

About Janus Living Inc. Class A-1 Common Stock

Janus Living, Inc. is a real estate investment trust that owns and operates senior housing communities in US. Its portfolio comprises roughly 34 communities across 10 states, structured under RIDEA arrangements and externally managed by Healthpeak Investment Management.

Read more on JAN →

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →